Berg Pharma Takes Big Data Small
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Berg’s Interrogative Biology discovery platform uses artificial intelligence to identify ways of correcting cell metabolism gone awry because of disease processes like cancer resistance.
You may also be interested in...
Drug Firm Pitches “World’s Strongest Antioxidant” To Beauty Brands
Firms including Estee Lauder, L'Oreal and AmorePacific show interest in Antipodean’s MitoQ “next generation CoQ10,” according to the development-phase pharmaceutical firm. Antipodean envisions MitoQ as a challenger to idebenone, found at 1% strength in Allergan’s Prevage MD anti-aging treatment.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.
Alzheimer’s, BRAIN Initiative Highlighted In $30 Billion NIH Budget Proposal
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.